Mini ways to stop a virus: MicroRNAs and HIV-1 replication

Future Virology

Volumn 6, Issue 2, 2011, Pages 209-221

  Chiang, Karen ^a   Rice, Andrew P ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

HIV restriction factors; HIV 1; latency; MIRNA

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3F; APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 3G; ARGONAUTE PROTEIN; CYCLIN T1; DICER; DOUBLE STRANDED RNA; DROSHA ENZYME; ESTERASE; EXPORTIN 5; GAG PROTEIN; GENOMIC RNA; HISTONE ACETYLTRANSFERASE PCAF; MICRORNA; NEF PROTEIN; P BODY PROTEIN; PIWI INTERACTING RNA; PROTEIN P19; PROTEIN P54; REV PROTEIN; RNA BINDING PROTEIN; RNA INDUCED SILENCING COMPLEX; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA; VIF PROTEIN; VIRUS ENVELOPE PROTEIN; VIRUS PROTEIN; VIRUS RNA; VPU PROTEIN;

3' UNTRANSLATED REGION; ANTIVIRAL ACTIVITY; CD4+ T LYMPHOCYTE; CELL VACUOLE; DRUG TARGETING; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HERPES VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LONG TERMINAL REPEAT; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; PYROSEQUENCING; REVIEW; RNA ANALYSIS; RNA INTERFERENCE; RNA STRUCTURE; RNA TRANSLATION; SIGNAL TRANSDUCTION; VIRION; VIROGENESIS; VIRUS GENOME; VIRUS IMMUNITY; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS LATENCY; VIRUS LOAD; VIRUS REACTIVATION; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TRANSCRIPTION; WILD TYPE;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79952584847     PISSN: 17460794     EISSN: None     Source Type: Journal    
DOI: 10.2217/fvl.10.92     Document Type: Review

References (116)

1. Kim VN, Han J, Siomi MC: Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 10(2), 126-139 (2009).
2. Okamura K, Lai EC: Endogenous small interfering RNAs in animals. Nat. Rev. Mol. Cell Biol. 9(9), 673-678 (2008).
3. OConnell RM, Rao DS, Chaudhuri AA, Baltimore D: Physiological and pathological roles for microRNAs in the immune system. Nat. Rev. Immunol. 10(2), 111-122 (2010).
4. Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat. Rev. Genet. 10(10), 704-714 (2009).
5. Inui M, Martello G, Piccolo S: MicroRNA control of signal transduction. Nat. Rev. Mol. Cell Biol. 11(4), 252-263 (2010).
6. Gangaraju VK, Lin H: MicroRNAs: key regulators of stem cells. Nat. Rev. Mol. Cell Biol. 10(2), 116-111 (2009).
7. Friedman RC, Farh KK, Burge CB, Bartel DP: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19(1), 92-105 (2009).
8. Miranda KC, Huynh T, Tay Y et al.: A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 126(6), 1203-1217 (2006). (Pubitemid 44380294)
9. Griffiths-Jones S, Saini HK, Van Dongen S, Enright AJ: miRBase: tools for microRNA genomics. Nucleic Acids Res. 36(Database issue), D154-D158 (2008). (Pubitemid 351149713)
10. Carthew RW, Sontheimer EJ: Origins and mechanisms of miRNAs and siRNAs. Cell 136(4), 642-655 (2009).
11. Borchert GM, Lanier W, Davidson BL: RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 13(12), 1097-1101 (2006). (Pubitemid 44885920)
12. Berezikov E, Chung WJ, Willis J, Cuppen E, Lai EC: Mammalian mirtron genes. Mol. Cell 28(2), 328-336 (2007). (Pubitemid 47600007)
13. Cole C, Sobala A, Lu C et al.: Filtering of deep sequencing data reveals the existence of abundant Dicer-dependent small RNAs derived from tRNAs. RNA 15(12), 2147-2160 (2009).
14. Haussecker D, Huang Y, Lau A, Parameswaran P, Fire AZ, Kay MA: Human tRNA-derived small RNAs in the global regulation of RNA silencing. RNA 16(4), 673-695 (2010).
15. Ender C, Krek A, Friedlander MR et al.: A human snoRNA with microRNA-like functions. Mol. Cell 32(4), 519-528 (2008).
16. Wang Y, Juranek S, Li H, Sheng G, Tuschl T, Patel DJ: Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex. Nature 456(7224), 921-926 (2008).
17. Landthaler M, Gaidatzis D, Rothballer A et al.: Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. RNA 14(12), 80-96 (2008).
18. Azuma-Mukai A, Oguri H, Mituyama T et al.: Characterization of endogenous human Argonautes and their miRNA partners in RNA silencing. Proc. Natl Acad. Sci. USA 105(23), 7964-7969 (2008). (Pubitemid 351904690)
19. Schmitter D, Filkowski J, Sewer A et al.: Effects of Dicer and Argonaute down-regulation on mRNA levels in human HEK293 cells. Nucleic Acids Res. 34(17), 4801-4815 (2006). (Pubitemid 44605625)
20. Liu J, Carmell MA, Rivas FV et al.: Argonaute2 is the catalytic engine of mammalian RNAi. Science 305(5689), 1437-1441 (2004). (Pubitemid 39167657)
21. Meister G, Landthaler M, Patkaniowska A, Dorsett Y, Teng G, Tuschl T: Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Mol. Cell 15(2), 185-197 (2004). (Pubitemid 38950966)
22. Liu J, Rivas FV, Wohlschlegel J, Yates Jr. 3rd, Parker R, Hannon GJ: A role for the P-body component GW182 in microRNA function. Nat. Cell Biol. 7(12), 1261-1266 (2005).
23. Schwarz DS, Hutvagner G, Du T, Xu Z, Aronin N, Zamore PD: Asymmetry in the assembly of the RNAi enzyme complex. Cell 115(2), 199-208 (2003). (Pubitemid 37329583)
24. Khvorova A, Reynolds A, Jayasena SD: Functional siRNAs and miRNAs exhibit strand bias. Cell 115(2), 209-216 (2003). (Pubitemid 37329584)
25. Ro S, Park C, Young D, Sanders KM, Yan W: Tissue-dependent paired expression of miRNAs. Nucleic Acids Res. 35(17), 5944-5953 (2007). (Pubitemid 47506308)
26. Chiang HR, Schoenfeld LW, Ruby JG et al.: Mammalian microRNAs: experimental evaluation of novel and previously annotated genes. Genes Dev. 24(10), 992-1009 (2010).
27. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB: Prediction of mammalian microRNA targets. Cell 115(7), 787-798 (2003). (Pubitemid 38058492)
28. Doench JG, Sharp PA: Specificity of microRNA target selection in translational repression. Genes Dev. 18(5), 504-511 (2004). (Pubitemid 38372808)
29. Baek D, Villen J, Shin C, Camargo FD, Gygi SP, Bartel DP: The impact of microRNAs on protein output. Nature 455(7209), 64-71 (2008).
30. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N: Widespread changes in protein synthesis induced by microRNAs. Nature 455(7209), 58-63 (2008).
31. Duursma AM, Kedde M, Schrier M, Le Sage C, Agami R: miR-148 targets human DNMT3b protein coding region. RNA 14(5), 872-877 (2008). (Pubitemid 351574909)
32. Forman JJ, Legesse-Miller A, Coller HA: A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc. Natl Acad. Sci. USA 105(39), 14879-14884 (2008).
33. Xie X, Lu J, Kulbokas EJ et al.: Systematic discovery of regulatory motifs in human promoters and 3́ UTRs by comparison of several mammals. Nature 434(7031), 338-345 (2005). (Pubitemid 40469170)
34. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136(2), 215-233 (2009).
35. Fabian MR, Sonenberg N, Filipowicz W: Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351-379 (2010).
36. Lim LP, Lau NC, Garrett-Engele P et al.: Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433(7027), 769-773 (2005). (Pubitemid 40292988)
37. Hendrickson DG, Hogan DJ, Mccullough HL et al.: Concordant regulation of translation and mRNA abundance for hundreds of targets of a human microRNA. PLoS Biol. 7(11), E1000238 (2009).
38. Guo H, Ingolia NT, Weissman JS, Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466(7308), 835-840 (2010).
39. Orom UA, Nielsen FC, Lund AH: MicroRNA-10a binds the 5́UTR of ribosomal protein mRNAs and enhances their translation. Mol. Cell 30(4), 460-471 (2008). (Pubitemid 351672378)
40. Vasudevan S, Tong Y, Steitz JA: Switching from repression to activation: microRNAs can up-regulate translation. Science 318(5858), 1931-1934 (2007).
41. Henke JI, Goergen D, Zheng J et al.: microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J. 27(24), 3300-3310 (2008).
42. Krol J, Loedige I, Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat. Rev. Genet. 11(9), 597-610 (2010).
43. Rechavi O, Erlich Y, Amram H et al.: Cell contact-dependent acquisition of cellular and viral nonautonomously encoded small RNAs. Genes Dev. 23(16), 1971-1979 (2009).
44. Ding SW, Voinnet O: Antiviral immunity directed by small RNAs. Cell 130(3), 413-426 (2007). (Pubitemid 47198311)
45. Mlotshwa S, Pruss GJ, Vance V: Small RNAs in viral infection and host defense. Trends Plant Sci. 13(7), 375-382 (2008).
46. Voinnet O: Origin, biogenesis, and activity of plant microRNAs. Cell 136(4), 669-687 (2009).
47. Voinnet O: Induction and suppression of RNA silencing: insights from viral infections. Nat. Rev. Genet. 6(3), 206-220 (2005). (Pubitemid 40293031)
48. Parameswaran P, Sklan E, Wilkins C et al.: Six RNA viruses and forty-one hosts: viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathog. 6(2), E1000764 (2010).
49. Lecellier CH, Dunoyer P, Arar K et al.: A cellular microRNA mediates antiviral defense in human cells. Science 308(5721), 557-560 (2005). (Pubitemid 40570587)
50. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P: Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309(5740), 1577-1581 (2005). (Pubitemid 41266486)
51. Lanford RE, Hildebrandt-Eriksen ES, Petri A et al.: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327(5962), 198-201 (2010).
52. Umbach JL, Cullen BR: The role of RNAi and microRNAs in animal virus replication and antiviral immunity. Genes Dev. 23(10), 1151-1164 (2009).
53. Bellare P, Ganem D: Regulation of KSHV lytic switch protein expression by a virus-encoded microRNA: an evolutionary adaptation that fine-tunes lytic reactivation. Cell Host Microbe 6(6), 570-575 (2009).
54. Cullen BR: Viral and cellular messenger RNA targets of viral microRNAs. Nature 457(7228), 421-424 (2009).
55. Ghosh Z, Mallick B, Chakrabarti J: Cellular versus viral microRNAs in host-virus interaction. Nucleic Acids Res. 37(4), 1035-1048 (2009).
56. Pfeffer S, Sewer A, Lagos-Quintana M et al.: Identification of microRNAs of the herpesvirus family. Nat. Methods 2(4), 269-276 (2005). (Pubitemid 41131008)
57. Cullen BR: Five questions about viruses and microRNAs. PLoS Pathog. 6(2), E1000787 (2010).
58. Klase Z, Kale P, Winograd R et al.: HIV-1 TAR element is processed by Dicer to yield a viral micro-RNA involved in chromatin remodeling of the viral LTR. BMC Mol. Biol. 8, 63 (2007).
59. Ouellet Dl, Plante I, Landry P et al.: Identification of functional microRNAs released through asymmetrical processing of HIV-1 TAR element. Nucleic Acids Res. 36(7), 2353-2365 (2008). (Pubitemid 351567008)
60. Omoto S, Ito M, Tsutsumi Y et al.: HIV-1 nef suppression by virally encoded microRNA. Retrovirology 1, 44 (2004).
61. Omoto S, Fujii YR: Regulation of human immunodeficiency virus 1 transcription by nef microRNA. J. Gen. Virol. 86(Pt 3), 751-755 (2005). (Pubitemid 40331255)
62. Lin J, Cullen BR: Analysis of the interaction of primate retroviruses with the human RNA interference machinery. J. Virol. 81(22), 12218-12226 (2007). (Pubitemid 350085837)
63. Landgraf P, Rusu M, Sheridan R et al.: A mammalian microRNA expression atlas based on small RNA library sequencing. Cell 129(7), 1401-1414 (2007). (Pubitemid 46970709)
64. Yeung ML, Bennasser Y, Watashi K, Le SY, Houzet L, Jeang KT: Pyrosequencing of small non-coding RNAs in HIV-1 infected cells: evidence for the processing of a viral-cellular double-stranded RNA hybrid. Nucleic Acids Res. 37(19), 6575-6586 (2009).
65. Bennasser Y, Le SY, Benkirane M, Jeang KT: Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22(5), 607-619 (2005). (Pubitemid 40719196)
66. Brown BD, Gentner B, Cantore A et al.: Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state. Nat. Biotechnol. 25(12), 1457-1467 (2007). (Pubitemid 350233144)
67. Klase Z, Winograd R, Davis J et al.: HIV-1 TAR miRNA protects against apoptosis by altering cellular gene expression. Retrovirology 6, 18 (2009).
68. Bowie AG, Unterholzner L: Viral evasion and subversion of pattern-recognition receptor signalling. Nat. Rev. Immunol. 8(12), 911-922 (2008).
69. Hale BG, Randall RE, Ortin J, Jackson D: The multifunctional NS1 protein of influenza A viruses. J. Gen. Virol. 89(Pt 10), 2359-2376 (2008).
70. Haasnoot J, De Vries W, Geutjes EJ, Prins M, De Haan P, Berkhout B: The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathog. 3(6), E86 (2007).
71. Qian S, Zhong X, Yu L, Ding B, De Haan P, Boris-Lawrie K: HIV-1 Tat RNA silencing suppressor activity is conserved across kingdoms and counteracts translational repression of HIV-1. Proc. Natl Acad. Sci. USA 106(2), 605-610 (2009).
72. Gatignol A, Buckler-White A, Berkhout B, Jeang KT: Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR. Science 251(5001), 1597-600 (1991). (Pubitemid 21916930)
73. Chendrimada TP, Gregory RI, Kumaraswamy E et al.: TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436(7051), 740-744 (2005). (Pubitemid 41117280)
74. Haase AD, Jaskiewicz L, Zhang H et al.: TRBP, a regulator of cellular PKR and HIV-1 virus expression, interacts with Dicer and functions in RNA silencing. EMBO Rep. 6(10), 961-967 (2005). (Pubitemid 41521952)
75. Bennasser Y, Yeung ML, Jeang KT: HIV-1 TAR RNA subverts RNA interference in transfected cells through sequestration of TAR RNA-binding protein, TRBP. J. Biol. Chem. 281(38), 27674-27678 (2006). (Pubitemid 44414481)
76. Christensen HS, Daher A, Soye KJ et al.: Small interfering RNAs against the TAR RNA binding protein, TRBP, a Dicer cofactor, inhibit human immunodeficiency virus type 1 long terminal repeat expression and viral production. J. Virol. 81(10), 5121-5131 (2007). (Pubitemid 46744423)
77. Daher A, Longuet M, Dorin D et al.: Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression. J. Biol. Chem. 276(36), 33899-33905 (2001).
78. Triboulet R, Mari B, Lin YL et al.: Suppression of microRNA-silencing pathway by HIV-1 during virus replication. Science 315(5818), 1579-1582 (2007). (Pubitemid 46449475)
79. Yeung ML, Bennasser Y, Myers TG, Jiang G, Benkirane M, Jeang KT: Changes in microRNA expression profiles in HIV-1- transfected human cells. Retrovirology 2, 81 (2005).
80. Houzet L, Yeung ML, De Lame V, Desai D, Smith SM, Jeang KT: MicroRNA profile changes in human immunodeficiency virus type 1 (HIV-1) seropositive individuals. Retrovirology 5, 118 (2008).
81. Kiernan RE, Vanhulle C, Schiltz L et al.: HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J. 18(21), 6106-6118 (1999). (Pubitemid 29515686)
82. Huang J, Wang F, Argyris E et al.: Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nat. Med. 13(10), 1241-1247 (2007). (Pubitemid 47530631)
83. Sung TL, Rice AP: miR-198 inhibits HIV-1 gene expression and replication in monocytes and its mechanism of action appears to involve repression of cyclin T1. PLoS Pathog. 5(1), E1000263 (2009).
84. Rice AP, Herrmann CH: Regulation of TAK/P-TEFb in CD4+ T lymphocytes and macrophages. Curr. HIV Res. 1(4), 395-404 (2003).
85. Coiras M, Lopez-Huertas MR, Perez- Olmeda M, Alcami J: Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs. Nat. Rev. Microbiol. 7(11), 798-812 (2009).
86. Han Y, Wind-Rotolo M, Yang HC, Siliciano JD, Siliciano RF: Experimental approaches to the study of HIV-1 latency. Nat. Rev. Microbiol. 5(2), 95-106 (2007). (Pubitemid 46151868)
87. Lassen KG, Bailey JR, Siliciano RF: Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo. J. Virol. 78(17), 9105-9114 (2004). (Pubitemid 39096521)
88. Chun TW, Justement JS, Lempicki RA et al.: Gene expression and viral prodution in latently infected, resting CD4+ T cells in viremic versus aviremic HIV-infected individuals. Proc. Natl Acad. Sci. USA 100(4), 1908-1913 (2003). (Pubitemid 36254547)
89. Wang X, Ye L, Hou W et al.: Cellular microRNA expression correlates with susceptibility of monocytes/macrophages to HIV-1 infection. Blood 113(3), 671-674 (2009).
90. Adams M, Sharmeen L, Kimpton J et al.: Cellular latency in human immunodeficiency virus-infected individuals with high CD4 levels can be detected by the presence of promoter-proximal transcripts. Proc. Natl Acad. Sci. USA 91(9), 3862-3866 (1994). (Pubitemid 24139532)
91. Lassen KG, Ramyar KX, Bailey JR, Zhou Y, Siliciano RF: Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells. PLoS Pathog. 2(7), E68 (2006).
92. Chun TW, Carruth L, Finzi D et al.: Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387(6629), 183-188 (1997). (Pubitemid 27209433)
93. Hariharan M, Scaria V, Pillai B, Brahmachari SK: Targets for human encoded microRNAs in HIV genes. Biochem. Biophys. Res. Commun. 337(4), 1214-1218 (2005). (Pubitemid 41505253)
94. Ahluwalia JK, Khan SZ, Soni K et al.: Human cellular microRNA hsa-miR-29a interferes with viral nef protein expression and HIV-1 replication. Retrovirology 5, 117 (2008).
95. Nathans R, Chu CY, Serquina AK, Lu CC, Cao H, Rana TM: Cellular microRNA and P bodies modulate host-HIV-1 interactions. Mol. Cell 34(6), 696-709 (2009).
96. Liu J, Valencia-Sanchez MA, Hannon GJ, Parker R: MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies. Nat. Cell Biol. 7(7), 719-723 (2005). (Pubitemid 40975754)
97. Sen GL, Blau HM: Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies. Nat. Cell Biol. 7(6), 633-636 (2005). (Pubitemid 40796987)
98. Pillai RS, Bhattacharyya SN, Artus CG et al.: Inhibition of translational initiation by Let-7 MicroRNA in human cells. Science 309(5740), 1573-1576 (2005). (Pubitemid 41266485)
99. Beckham CJ, Parker R: P bodies, stress granules, and viral life cycles. Cell Host Microbe 3(4), 206-212 (2008). (Pubitemid 351494719)
100. Chable-Bessia C, Meziane O, Latreille D et al.: Suppression of HIV-1 replication by microRNA effectors. Retrovirology 6, 26 (2009).
101. Wichroski MJ, Robb GB, Rana TM: Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodies. PLoS Pathog. 2(5), E41 (2006).
102. Wang X, Han Y, Dang Y et al.: Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication. J. Biol. Chem. 285(19), 14346-14355
103. Burdick R, Smith JL, Chaipan C et al.: P body-associated protein MOV10 inhibits HIV-1 replication at multiple stages. J. Virol. 84(19), 10241-10210.3
104. Schnieke A, Stuhlmann H, Harbers K, Chumakov I, Jaenisch R: Endogenous Moloney leukemia virus in nonviremic Mov substrains of mice carries defects in the proviral genome. J. Virol. 45(2), 505-513 (1983). (Pubitemid 13225414)
105. Mooslehner K, Muller U, Karls U, Hamann L, Harbers K: Structure and expression of a gene encoding a putative GTP-binding protein identified by provirus integration in a transgenic mouse strain. Mol. Cell Biol. 11(2), 886-893 (1991). (Pubitemid 21895437)
106. Fairman-Williams ME, Guenther UP, Jankowsky E: SF1 and SF2 helicases: family matters. Curr. Opin. Struct. Biol. 20(3), 313-324
107. Dalmay T, Horsefield R, Braunstein TH, Baulcombe DC: SDE3 encodes an RNA helicase required for post-transcriptional gene silencing in Arabidopsis. EMBO J. 20(8), 2069-2078 (2001).
108. Meister G, Landthaler M, Peters L et al.: Identification of novel argonaute-associated proteins. Curr Biol 15(23), 2149-2155 (2005). (Pubitemid 41739749)
109. Chendrimada TP, Finn KJ, Ji X et al.: MicroRNA silencing through RISC recruitment of eIF6. Nature 447(7146), 823-828 (2007). (Pubitemid 46920131)
110. Haussecker D, Cao D, Huang Y, Parameswaran P, Fire AZ, Kay MA: Capped small RNAs and MOV10 in human hepatitis delta virus replication. Nat. Struct. Mol. Biol. 15(7), 714-721 (2008). (Pubitemid 351932001)
111. Gallois-Montbrun S, Kramer B, Swanson CM et al.: Antiviral protein APOBEC3G localizes to ribonucleoprotein complexes found in P bodies and stress granules. J. Virol. 81(5), 2165-2178 (2007).
112. Gallois-Montbrun S, Holmes RK, Swanson CM et al.: Comparison of cellular ribonucleoprotein complexes associated with the APOBEC3F and APOBEC3G antiviral proteins. J. Virol. 82(11), 5636-5642 (2008). (Pubitemid 351705270)
113. Kozak SL, Marin M, Rose KM, Bystrom C, Kabat D: The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules. J. Biol. Chem. 281(39), 29105-29119 (2006). (Pubitemid 44507054)
114. Furtak V, Mulky A, Rawlings SA et al.: Perturbation of the P-body component MOV10 inhibits HIV-1 infectivity. PLoS ONE 5(2), E9081 (2010).
115. Coley W, Van Duyne R, Carpio L et al.: Absence of DICER in monocytes and its regulation by HIV-1. J. Biol. Chem. 285(42), 31930-31943 (2010).
116. Chi SW, Zang JB, Mele A, Darnell RB: Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps. Nature 460(7254), 479-486 (2009).